Literature DB >> 26067265

Transcervical chorionic villus sampling: a practical guide.

Iosifina Stergiotou1, Virginia Borobio1, Mar Bennasar1, Anna Goncé1, Raquel Mula1, Mohammed Nuruddin1, Anna Soler1, Antoni Borrell1.   

Abstract

First trimester screening for fetal aneuploidies has made the implementation of diagnostic techniques essential. Chorionic villus sampling (CVS) is the method of choice for obtaining chorionic villi for molecular and cytogenetic analysis in the first trimester. Two techniques have been developed, a transcervical and a transabdominal. The selection criteria have been based historically on factors, such as placental location, parity, maternal weight and preference of the operator. In our institution, we developed an elevated level of expertise in the field of transcervical approach, resulting in good quality of samples and comparable fetal loss rate to other approaches. Despite three decades of transcervical CVS performance, little consensus in terms of its technique and clinical guidelines exists. Considering the expertise and the volume of procedures performed at our center, we suggest a practical clinical guideline for transcervical CVS.

Keywords:  Aneuploidy; chorionic villus sampling; genetic testing; practical guide; prenatal diagnosis

Mesh:

Year:  2015        PMID: 26067265     DOI: 10.3109/14767058.2015.1043261

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

1.  Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.

Authors:  Yuval Yaron; Montse Pauta; Celia Badenas; Anna Soler; Virginia Borobio; Carmen Illanes; Fernanda Paz-Y-Miño; Raigam Martinez-Portilla; Antoni Borrell
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

2.  Decision aids that support decisions about prenatal testing for Down syndrome: an environmental scan.

Authors:  Maria Esther Leiva Portocarrero; Mirjam M Garvelink; Maria Margarita Becerra Perez; Anik Giguère; Hubert Robitaille; Brenda J Wilson; François Rousseau; France Légaré
Journal:  BMC Med Inform Decis Mak       Date:  2015-09-24       Impact factor: 2.796

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.